Antibiotice SA 2014 Annual Report with Sustainability Disclosures
The report highlights S.C. Antibiotice S.A.'s performance and strategic achievements during the 2014 fiscal year. The company consolidated its position as the leading Romanian manufacturer of generic drugs, expanding its international presence to 73 countries and maintaining its global leadership in Nystatin API production. Key investments included a new raw materials warehouse and dedicated quality control laboratories. On the environmental front, the company maintained its Integrated Management System certifications and successfully managed its resource consumption and waste recycling programs.
Company: Antibiotice SA
Sector: Manufacturing
Country: Romania
Year: 2014
Type: Annual Report with Sustainability Disclosures
Pages: 76
Back to company
Antibiotice SA
Annual Report
The report highlights S.C. Antibiotice S.A.'s performance and strategic achievements during the 2014 fiscal year. The company consolidated its position as the leading Romanian manufacturer of generic drugs, expanding its international presence to 73 countries and maintaining its global leadership in Nystatin API production. Key investments included a new raw materials warehouse and dedicated quality control laboratories. On the environmental front, the company maintained its Integrated Management System certifications and successfully managed its resource consumption and waste recycling programs.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2014
Reporting Period
Jan 1, 2014 - Dec 31, 2014
Fiscal Year
2014
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Water Consumption
Employees